195 related articles for article (PubMed ID: 10615074)
21. Adverse outcome of pregnancies with extremely high levels of maternal serum human chorionic gonadotropin.
Sharony R; Itzhaky D; Amiel A; Hershko A; Grinshpoon Y; Fejgin M
Fetal Diagn Ther; 2008; 23(3):233-6. PubMed ID: 18417984
[TBL] [Abstract][Full Text] [Related]
22. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
23. First-trimester intrauterine hematoma and outcome of pregnancy.
Maso G; D'Ottavio G; De Seta F; Sartore A; Piccoli M; Mandruzzato G
Obstet Gynecol; 2005 Feb; 105(2):339-44. PubMed ID: 15684162
[TBL] [Abstract][Full Text] [Related]
24. The influence of gestational age and smoking habits on the risk of subsequent preterm deliveries.
Cnattingius S; Granath F; Petersson G; Harlow BL
N Engl J Med; 1999 Sep; 341(13):943-8. PubMed ID: 10498489
[TBL] [Abstract][Full Text] [Related]
25. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
[TBL] [Abstract][Full Text] [Related]
26. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
27. Decreased first-trimester maternal serum free-beta subunit human chorionic gonadotropin and preterm birth in twin gestations.
Laughon SK; Rebarber A; Rolnitzky L; Fink L; Saltzman DH
Am J Perinatol; 2009 Aug; 26(7):491-4. PubMed ID: 19288397
[TBL] [Abstract][Full Text] [Related]
28. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
Spencer K
Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
[TBL] [Abstract][Full Text] [Related]
29. Elevated second trimester human chorionic gonadotropin level associated with adverse pregnancy outcome.
Onderoğlu LS; Kabukçu A
Int J Gynaecol Obstet; 1997 Mar; 56(3):245-9. PubMed ID: 9127156
[TBL] [Abstract][Full Text] [Related]
30. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
31. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome.
Huang T; Hoffman B; Meschino W; Kingdom J; Okun N
Prenat Diagn; 2010 May; 30(5):471-7. PubMed ID: 20440736
[TBL] [Abstract][Full Text] [Related]
32. Pregnancy outcomes in unselected singleton pregnant women with an increased risk of first-trimester Down's syndrome.
Liu SS; Lee FK; Lee JL; Tsai MS; Cheong ML; She BQ; Chen SC
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1130-4. PubMed ID: 15548144
[TBL] [Abstract][Full Text] [Related]
33. Do delayed childbearers face increased risks of adverse pregnancy outcomes after the first birth?
Cnattingius S; Berendes HW; Forman MR
Obstet Gynecol; 1993 Apr; 81(4):512-6. PubMed ID: 8459958
[TBL] [Abstract][Full Text] [Related]
34. Trauma during pregnancy: an analysis of maternal and fetal outcomes in a large population.
El-Kady D; Gilbert WM; Anderson J; Danielsen B; Towner D; Smith LH
Am J Obstet Gynecol; 2004 Jun; 190(6):1661-8. PubMed ID: 15284764
[TBL] [Abstract][Full Text] [Related]
35. Smoking in early gestation or through pregnancy: a decision crucial to pregnancy outcome.
Raatikainen K; Huurinainen P; Heinonen S
Prev Med; 2007 Jan; 44(1):59-63. PubMed ID: 16959307
[TBL] [Abstract][Full Text] [Related]
36. First-trimester bleeding and pregnancy outcome in singletons after assisted reproduction.
De Sutter P; Bontinck J; Schutysers V; Van der Elst J; Gerris J; Dhont M
Hum Reprod; 2006 Jul; 21(7):1907-11. PubMed ID: 16501033
[TBL] [Abstract][Full Text] [Related]
37. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
38. First trimester predictors of adverse pregnancy outcomes.
Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
[TBL] [Abstract][Full Text] [Related]
39. Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin.
Towner D; Gandhi S; El Kady D
Am J Obstet Gynecol; 2006 Jun; 194(6):1676-81; discussion 1681-2. PubMed ID: 16643816
[TBL] [Abstract][Full Text] [Related]
40. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies.
Lepage N; Chitayat D; Kingdom J; Huang T
Am J Obstet Gynecol; 2003 May; 188(5):1354-9. PubMed ID: 12748511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
